Beatrice Setnik

Evaluation of the abuse potential of pitolisant, a selective H3-receptor antagonist/inverse agonist, for the treatment of adult patients with narcolepsy with or without cataplexy

Beatrice Setnik, Michael McDonnell, Catherine Mills et al. · SLEEP · 2019 · 187 citations · Full text

Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial

Kerri A. Schoedel, Isabella Szeto, Beatrice Setnik et al. · Epilepsy & Behavior · 2018 · 164 citations · Full text

Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendations

Sandra D. Comer, James P. Zacny, Robert H. Dworkin et al. · Pain · 2012 · 72 citations · Full text

Opioid Epidemic, Substance Use, Drug Assessment +18

Subjective Effects and Safety of Whole and Tampered Morphine Sulfate and Naltrexone Hydrochloride (ALO-01) Extended-Release Capsules versus Morphine Solution and Placebo in Experienced Non-Dependent Opioid Users

Joseph Stauffer, Beatrice Setnik, Marta Sokolowska et al. · Clinical Drug Investigation · 2009 · 53 citations

Opioid Epidemic, Pain Medicine, Subjective Effects +16

Assessment, stratification, and monitoring of the risk for prescription opioid misuse and abuse in the primary care setting

James A. Brown, Beatrice Setnik, Keung Lee et al. · Journal of Opioid Management · 2017 · 51 citations